Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
opioid
3
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
3
×
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
cancer
cancer immunotherapy
clinical trials
deals
drug prices
johnson & johnson
nonalcoholic steatohepatitis
sanofi
startups
2019
abbvie
What
drug
3
×
roundup
approval
bio
advanced
ahead
alnylam’s
ambien
american
annual
asco
attendees
attention
bff
biogen’s
biopharmaceutical
biotech
camp’s
cancer
cash
chicago
city
clinical
combinations
community’s
companies
conference
convo
days
deals
devoted
disease
earlier
easl
expanding
failures
focus
form
gene
home
Language
Current search:
opioid
×
" seattle blog main "
×
drug
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
